144 related articles for article (PubMed ID: 10225758)
21. Polycythemia vera: scientific advances and current practice.
Tefferi A; Spivak JL
Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
[TBL] [Abstract][Full Text] [Related]
22. A clinical analysis of erythrocytapheresis for the treatment of polycythemia.
Liu H; Liu H; Shen J; Sun C; Guo C; Lin H; Yao J; Ma R; Zhang M
Transfus Apher Sci; 2013 Apr; 48(2):229-33. PubMed ID: 23428426
[TBL] [Abstract][Full Text] [Related]
23. Polycythemia vera.
Murphy S
Dis Mon; 1992 Mar; 38(3):153-212. PubMed ID: 1587207
[TBL] [Abstract][Full Text] [Related]
24. [Effect of bloodletting on the proliferative activity of erythroid progenitor cells from the bone marrow of patients with polycythemia and polycythemia vera].
Hansz J; Kozłowska-Skrzypczak M
Pol Arch Med Wewn; 1991 Sep; 86(3):125-31. PubMed ID: 1808597
[TBL] [Abstract][Full Text] [Related]
25. The role of erythrocytapheresis in secondary erythrocytosis therapy.
Pollari G; Antonini V; Izzo A; Moreschini G; Serraino M; Tonelli V; D'Angiolino A; Migliaccio M
Clin Hemorheol Microcirc; 1999; 21(3-4):353-5. PubMed ID: 10711770
[TBL] [Abstract][Full Text] [Related]
26. In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia.
Shih LY; Lee CT; See LC; Ou YC; Dunn P; Wang PN; Kuo MC; Wu JH
Eur J Clin Invest; 1998 Jul; 28(7):569-76. PubMed ID: 9726038
[TBL] [Abstract][Full Text] [Related]
27. [Alpha interferon in the therapy of polycythemia vera].
Castello G; Lerza R; Cavallini D; Ballarino P; Cerruti A; Bogliolo G; Pannacciulli I
Recenti Prog Med; 1996 Jan; 87(1):7-11. PubMed ID: 8711255
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular events and intensity of treatment in polycythemia vera.
Marchioli R; Finazzi G; Specchia G; Cacciola R; Cavazzina R; Cilloni D; De Stefano V; Elli E; Iurlo A; Latagliata R; Lunghi F; Lunghi M; Marfisi RM; Musto P; Masciulli A; Musolino C; Cascavilla N; Quarta G; Randi ML; Rapezzi D; Ruggeri M; Rumi E; Scortechini AR; Santini S; Scarano M; Siragusa S; Spadea A; Tieghi A; Angelucci E; Visani G; Vannucchi AM; Barbui T;
N Engl J Med; 2013 Jan; 368(1):22-33. PubMed ID: 23216616
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of erythrocytapheresis compared to phlebotomy in polycythaemia vera patients.
Cabibbo S; Manenti GO; Antolino A; Poidomani M; Elia R; Palumbo G; DiRaimondo F
Hematol Transfus Cell Ther; 2023 Aug; ():. PubMed ID: 37718130
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the influence of body weight index to the result of therapeutic erythrocytapheresis in patients with polycythemia vera.
Bai J; Zhang L; Hu X; Xue Y; Long F; Zhang B; Yan S
Transfus Apher Sci; 2012 Dec; 47(3):295-9. PubMed ID: 22990001
[TBL] [Abstract][Full Text] [Related]
31. Polycythemia vera treated with pipobroman as single agent: low incidence of secondary leukemia in a cohort of patients observed during 20 years (1971-1991).
Petti MC; Spadea A; Avvisati G; Spadea T; Latagliata R; Montefusco E; Cosenza M; Malagnino F
Leukemia; 1998 Jun; 12(6):869-74. PubMed ID: 9639413
[TBL] [Abstract][Full Text] [Related]
32. Treatment of polycythemia vera.
Silver RT
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):437-42. PubMed ID: 16810620
[TBL] [Abstract][Full Text] [Related]
33. Contemporary approach to essential thrombocythemia and polycythemia vera.
Aruch D; Mascarenhas J
Curr Opin Hematol; 2016 Mar; 23(2):150-60. PubMed ID: 26717193
[TBL] [Abstract][Full Text] [Related]
34. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894
[TBL] [Abstract][Full Text] [Related]
35. Automated red blood cell depletion: Results from a validation trial of the Fenwal Amicus new red blood cell depletion program.
Sanderson F; Cauchois R; Berda-Haddad Y; Poullin P
J Clin Apher; 2020 Aug; 35(4):335-341. PubMed ID: 32619335
[TBL] [Abstract][Full Text] [Related]
36. [Erythron in patients with polycythemia vera during treatment by erythrocytapheresis and bloodletting].
Gudim VI; Sarycheva TG; Kotel'nikov VM; Melikian AL; Ivanova VS
Ter Arkh; 1987; 59(6):48-51. PubMed ID: 3629498
[TBL] [Abstract][Full Text] [Related]
37. Increased serum levels of vascular endothelial growth factor correlate with splenomegaly in polycythemia vera.
Murphy P; Ahmed N; Hassan HT
Leuk Res; 2002 Nov; 26(11):1007-1010. PubMed ID: 12363469
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and therapy of polycythemia vera.
Lengfelder E; Merx K; Hehlmann R
Semin Thromb Hemost; 2006 Apr; 32(3):267-75. PubMed ID: 16673281
[TBL] [Abstract][Full Text] [Related]
39. Primary polycythaemia vera in the elderly.
Abyad A; Kligman E
J Int Med Res; 1994; 22(2):121-9. PubMed ID: 8020639
[TBL] [Abstract][Full Text] [Related]
40. Diagnosing polycythemia vera: a paradigm shift.
Tefferi A
Mayo Clin Proc; 1999 Feb; 74(2):159-62. PubMed ID: 10069355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
